| 000 | 01531 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512023524.0 | ||
| 264 | 0 | _c19870702 | |
| 008 | 198707s 0 0 eng d | ||
| 022 | _a0028-0836 | ||
| 024 | 7 |
_a10.1038/327324a0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aD'Amato, R J | |
| 245 | 0 | 0 |
_aEvidence for neuromelanin involvement in MPTP-induced neurotoxicity. _h[electronic resource] |
| 260 |
_bNature _c |
||
| 300 |
_a324-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCaudate Nucleus _xmetabolism |
| 650 | 0 | 4 |
_aChloroquine _xtherapeutic use |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aHomovanillic Acid _xmetabolism |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanins _xmetabolism |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xmetabolism |
| 650 | 0 | 4 |
_aNeurons _xmetabolism |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 |
_aPutamen _xmetabolism |
| 650 | 0 | 4 |
_aPyridines _xmetabolism |
| 650 | 0 | 4 |
_aSubstantia Nigra _xmetabolism |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 700 | 1 | _aAlexander, G M | |
| 700 | 1 | _aSchwartzman, R J | |
| 700 | 1 | _aKitt, C A | |
| 700 | 1 | _aPrice, D L | |
| 700 | 1 | _aSnyder, S H | |
| 773 | 0 |
_tNature _gvol. 327 _gno. 6120 _gp. 324-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/327324a0 _zAvailable from publisher's website |
| 999 |
_c2890413 _d2890413 |
||